- Home
- SOWG vs GNTA Comparison
SOWG vs GNTA Comparison
Compare SOWG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOWG | GNTA |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.9M | 62.7M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SOWG | GNTA |
|---|---|---|
| Price | $3.23 | $0.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.9K | ★ 36.9K |
| Earning Date | 05-15-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $0.55 |
| 52 Week High | $4.45 | $10.00 |
Technical Indicators
Market Signals| Indicator | SOWG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 29.90 |
| Support Level | $2.45 | $0.58 |
| Resistance Level | $3.65 | $0.91 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 5.28 | 13.53 |
Price Performance
Historical ComparisonAbout SOWG Sow Good Inc.
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.